Open AccessCo-treatment with pegylated interferon alfa-2a and entecavir for hepatitis D: A randomized trial
Author(s) -
Zaigham Abbas,
Mohammad Sadik Memon,
Muhammad Umer,
Minaam Abbas,
Lubna Shazi
Publication year - 2016
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v8.i14.625
Subject(s) - medicine , entecavir , hbsag , gastroenterology , pegylated interferon , combination therapy , randomized controlled trial , hepatitis d , hepatitis d virus , hepatitis b , immunology , hepatitis b virus , virus , chronic hepatitis , ribavirin , lamivudine
To investigate the efficacy of pegylated interferon alfa (PEG-IFNα) therapy with and without entecavir in patients with chronic hepatitis D.